• Our take on the REACH losmapimod clinical trial results

  • Sep 19 2024
  • Duración: 1 h y 58 m
  • Podcast

Our take on the REACH losmapimod clinical trial results

  • Resumen

  • "I always tell the truth, even when I lie." Today we are joined by our CRISPR Goddess and cover the Fulcrum Therapeutics REACH phase 3 clinical trial data release and discuss our journey with Fulcrum from the beginning. While very disappointing from several aspects, in the end a lot of benefit truly has been gained for the FSHD field and we are grateful for Fulcrum's contributions to help others going forward. And there are many others coming along, this is the beginning and not the end for FSHD therapeutics.

    Más Menos

Lo que los oyentes dicen sobre Our take on the REACH losmapimod clinical trial results

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.